SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending following a significant leadership transition announcement, with CEO Shantanu Narayen set to step down while the company maintains strong earnings beats and reaffirmed guidance. The community remains deeply divided, with some investors viewing the price drop as a prime buying opportunity for a financially healthy company, while others express concerns that artificial intelligence is structurally eroding its competitive moat.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors debate the binary outcome of recent short-seller allegations, with the community closely tracking the company's aggressive debt reduction efforts and potential short squeeze dynamics. Bullish participants are pointing to the firm's significant holdings in companies like $BW and $APLD as undervalued assets, while some remain cautious due to ongoing filing delays and high volatility.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is experiencing a surge in social media attention as its community rallies behind a 'culture-first' narrative ahead of April 20, drawing comparisons to Bitcoin's trajectory. Supporters are actively engaging in educational discussions around cannabis-related scientific research and policy trends while leveraging the Solana ecosystem to promote the token's growth.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is seeing significant market activity and community interest following a development agreement with Tower Semiconductor to integrate its electro-optic polymer modulators into the PH18 silicon photonics platform. Traders are actively debating the stock's potential for AI infrastructure integration versus concerns over its pre-revenue status and dilution risks, while many are focused on upcoming industry conferences as potential catalysts for further momentum.

CF Industries Holdings, Inc. engages in the manufacture and distribution of nitrogen fertilizer. The firm owns and operates nitrogen plants and serves agricultural and industrial customers through its distribution system. It operates through the following segments: Ammonia, Granular Urea, UAN, AN, and Other. The Ammonia segment produces anhydrous ammonia. The Granular Urea segment offers granular urea. The UAN segment focuses on urea ammonium nitrate solution. The AN segment refers to the production of ammonium nitrate. The Other segment includes diesel exhaust fluid, nitric acid, urea liquor, and aqua ammonia. The company was founded in 1946 and is headquartered in Northbrook, IL.

CF Industries Holdings Inc

CF Industries is trending as investors weigh strong operational results against concerns over nitrogen price volatility and global demand shifts. Community discussions are heavily focused on the company's valuation, its strategic pivot toward low-carbon ammonia, and how the ongoing energy cost landscape impacts future growth.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is currently experiencing heightened community interest driven by its position as the first-to-market needle-free epinephrine treatment, with investors closely monitoring its global expansion efforts and potential short squeeze dynamics. While some market participants debate the long-term competition from pending alternative treatments, others are focused on the stock's constrained float and fundamental progress in scaling adoption for anaphylaxis and urticaria.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors actively debate its long-term potential amid significant price volatility and ongoing community discussions regarding the impact of the ASI alliance and strategic partnerships. The community remains polarized, with many buyers viewing current price levels as a deep-discount accumulation opportunity, while others express frustration over recent performance and skepticism regarding broader market conditions.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq Inc. is trending as investors monitor its upcoming quarterly earnings report and strategic AI-powered enhancements to its market surveillance platform. The broader community remains focused on how the exchange's diversification into digital assets and technology infrastructure positions it against shifting macroeconomic conditions and potential market volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a surge in investor attention and volume as the community anticipates major product demonstrations at the upcoming OFC Conference. The conversation is heavily focused on the company's potential for scaling production of its optical engines to address AI data center bottlenecks, with many investors actively tracking partnerships and speculating on looming commercial announcements.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing a surge in trading volume and bullish sentiment driven by its role as a critical supplier for Co-Packaged Optics (CPO) and silicon photonics within the Nvidia AI hardware ecosystem. Investors are actively debating the timing of mass production and potential revenue inflection points, while closely monitoring technical breakouts and significant option activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMRSQ One of the most precarious phases of large-scale fermentation is the biomass accumulation phase. This is when yeast are allowed to multiply to reach a high density of cells ready to commence synthesis. During this phase, some cells will develop mutations that allow them to escape synthesis, creating a fitness advantage. This advantage allows them to propagate more quickly than the other cells, overwhelming the population with mutant yeast cells that will not be productive (thereby destroying yield). 

The recent patent filing below reveals Amyris scientists found that if they introduced an “on/off switch”, which would suppress production until the switch is flipped, the strains were considerably more stable. One “switch” is oxygen sensitive, so that when a controlled amount of oxygen is introduced (micro aerobic conditions), synthesis will start. The other “switch” is the simple sugar maltose, which can be added after the accumulation phase is complete. 

https://patentscope.wipo.int/search/en/detail.jsf?docId=US304654671&amp;tab=PCTDESCRIPTION&amp;_cid=P20-KFBS1U-58832-1

Tom Cross

GreenAndGreen

HulkSmash

K Fujii

D Cup

AaronGLow

Rodger Rodger

EpicurusFan

KnysnaNow

Nukie

auntmarie

SomewhatMemorable

John

Fant Winter

Investor

N808

recentlyChanged

Kelly Woods

fernando

Optionsna1st

Peter

BearGuru

Salesmaster99

Yoda

Ken Holmes

Onfish2000

Ian Asgard

The present disclosure relates to the use of a switch for the production of heterologous non-catabolic compounds in microbial host cells. In one aspect, provided herein are genetically modified microorganisms that produce non-catabolic compounds more stably when serially cultured under aerobic conditions followed by microaerobic conditions, and methods of producing non-catabolic compounds by culturing the genetically modified microbes under such culture conditions.

Wipo

US20200270643 METHODS FOR STABILIZING PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

StockTwits for iOS

Amyris Inc

$AMRS One of the most precarious phases of large-scale fermentation is the biomass accumulation phase. This is when yeast are allowed to multiply to reach a high density of cells ready to commence synthesis. During this phase, some cells will develop mutations that allow them to escape synthesis, creating a fitness advantage. This advantage allows them to propagate more quickly than the other cells, overwhelming the population with mutant yeast cells that will not be productive (thereby destroying yield). 

The recent patent filing below reveals Amyris scientists found that if they introduced an “on/off switch”, which would suppress production until the switch is flipped, the strains were considerably more stable. One “switch” is oxygen sensitive, so that when a controlled amount of oxygen is introduced (micro aerobic conditions), synthesis will start. The other “switch” is the simple sugar maltose, which can be added after the accumulation phase is complete. 



IonQ Inc

Wiffle1

@Wiffle1 

In your estimate, what are the implications of this advancement? Do you think it creates a moat that other synthbio firms will have to contend with? Or is this merely a natural progression that all leading synthbio firms will have to go through at some point?

StockTwits Web

 

In your estimate, what are the implications of this advancement? Do you think it creates a moat that other synthbio firms will have to contend with? Or is this merely a natural progression that all leading synthbio firms will have to go through at some point?

@GreenAndGreen Great question. Anyone using organisms for synthesis from bacteria to yeast to mammalian cell lines uses a simple switch to control synthesis. The problem is that those simple switches are often “leaky”, which means you get some synthesis when you don’t want it - and that is where the mutational problems arise. 

What differentiates this patent is that they have tied synthesis to an additional on/off switch (on top of the standard/pre-existing one) dependent on oxygen, allowing for much tighter regulation and control. I’m not an expert in yeast, but this approach is pretty creative/novel, and their data suggests it has real implications for strain stability. The best part is that this approach can be applied to any industrial fermentation process, so it could affect their whole pipeline. So to answer your question, their moat is absolutely getting wider.

Ben M

T_Woo

Firegamerx

 Great question. Anyone using organisms for synthesis from bacteria to yeast to mammalian cell lines uses a simple switch to control synthesis. The problem is that those simple switches are often “leaky”, which means you get some synthesis when you don’t want it - and that is where the mutational problems arise. 

What differentiates this patent is that they have tied synthesis to an additional on/off switch (on top of the standard/pre-existing one) dependent on oxygen, allowing for much tighter regulation and control. I’m not an expert in yeast, but this approach is pretty creative/novel, and their data suggests it has real implications for strain stability. The best part is that this approach can be applied to any industrial fermentation process, so it could affect their whole pipeline. So to answer your question, their moat is absolutely getting wider.

@Wiffle1 thanks for the education. Really appreciate it.

 thanks for the education. Really appreciate it.

Sunpower Corp

T1 Energy Inc.

ImmunityBio Inc

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Enovix Corp

Energy Vault Holdings Inc

Fluence Energy Inc - Ordinary Shares - Class A

@Wiffle1 SIMPLY SUPERIOR, AND MOST USEFUL POST.  Thanks most kindly @Wiffle1

 SIMPLY SUPERIOR, AND MOST USEFUL POST.  Thanks most kindly 

Purple Biotech Ltd - ADR

@Wiffle1 No production manager wants to deal with this or dual end products (farnesene + carotenoids). Pie-in-the-sky.

 No production manager wants to deal with this or dual end products (farnesene + carotenoids). Pie-in-the-sky.